Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio (2020 - 2026)

Mirum Pharmaceuticals' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 218.33 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio fell 5070.9% year-over-year to 218.33; the TTM figure through Mar 2026 stood at 55.27 (down 937.79% YoY), while the FY2025 annual figure was 1.54, up 74.87% from the prior year.
• Interest Coverage Ratio was 218.33 for Q1 2026 at Mirum Pharmaceuticals, down from 1.27 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.72 in Q3 2025 to a low of 218.33 in Q1 2026.
• Historically, Interest Coverage Ratio has averaged 18.29 across 5 years, with a median of 6.79 in 2024.
• The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio jumped 120.41% in 2025, then sank 5070.9% in 2026.
• A 5-year view of Interest Coverage Ratio shows it stood at 7.84 in 2022, then declined by 16.7% to 9.15 in 2023, then gained by 26.0% to 6.77 in 2024, then soared by 81.24% to 1.27 in 2025, then sank by 17100.24% to 218.33 in 2026.
• The last three Interest Coverage Ratio figures came in at 218.33 (Q1 2026), 1.27 (Q4 2025), and 0.72 (Q3 2025), per Business Quant data.